TRANSLATION IN HEALTHCARE Plenary V – Where Do We Go From Here? Lecture Theatre 2 Prof. Madeleine Murtagh, University of Bristol, UK Prof. Eric Juengst, University of North Carolina, USA Prof. Kazuto Kato, Osaka University, Japan Prof. Eric Meslin, Indiana University, USA Prof. Amy McGuire, Baylor College of Medicine, USA Prof. Sigrid Sterckx, Ghent University, Belgium Chair: Prof. Jane Kaye University of Oxford, UK Thurs. 25 June 2015

WHAT IS THE BEST PUB IN OXFORD A. Royal Oak B. Egg & Dinosaur C. The Turf D. The Dodo

WHAT WERE THE BREAK OUT SESSIONS CALLED A. Putt Putt B. Machu Peccau C. Pecha Kucha D. Kuchi Kuchi

WOULD YOU COME TO ANOTHER ELSI 2.0 CONFERENCE IN OXFORD A. No, Never again B. Next year C. In 2 years time D. In 3 years time

WHO WILL BE CLINICIANS OF THE FUTURE A. Bioinformaticians B. Geneticists C. Primary Care Doctors D. Citizens E. Pharmacists

IS TRANSLATION: A. Pipeline B. Thicket C. Peaks & Valleys D. Cycle of Chaos

SHOULD GOVERNMENTS BE ABLE TO SELL ACCESS TO PATIENT DATA A. Yes B. No

WHEN CAN WE OVERRIDE PRIVACY CONCERNS TO REALISE THE BENEFITS OF BIG DATA APPROACHES A. Never B. Only if people give consent C. Decided via participatory governance procedure D. If it has been decided by parliament

. DOES IT MATTER WHETHER A PUBLIC GOOD (DRUG, TREATMENT ETC) IS PRODUCED BY A COMMERCIAL ORGANISATION OR A PUBLIC ONE A. Commercial B. Public

. DOES IT MATTER WHETHER A PUBLIC GOOD (DRUG, TREATMENT ETC) IS PRODUCED BY A COMMERCIAL ORGANISATION OR A PUBLIC ONE - IMAGINE YOU ARE A PATIENT WITH ADVANCED BREAST CANCER A. Commercial B. Public

. DOES IT MATTER WHETHER A PUBLIC GOOD (DRUG, TREATMENT ETC) IS PRODUCED BY A COMMERCIAL ORGANISATION OR A PUBLIC ONE - IMAGINE YOU ARE A PATIENT WITH MILD ASTHMA? A. Commercial B. Public

. DOES IT MATTER WHETHER A PUBLIC GOOD (DRUG, TREATMENT ETC) IS PRODUCED BY A COMMERCIAL ORGANISATION OR A PUBLIC ONE - IMAGINE YOU ARE A HOSPITAL MANAGER? A. Commercial B. Public

. DO DISCUSSIONS ABOUT TRANSLATION MISS WHETHER PATIENTS AND PROFESSIONALS ARE TALKING ABOUT THE SAME THING A. Yes B. No

.. IS IT ALL ABOUT GENETIC TECHNOLOGIES AND RARE DISEASE A. Yes B. No

. TRANSLATION IS A PROCESS NOT A PROMISE A. Yes B. No

TRANSLATION IN HEALTHCARE Plenary V – Where Do We Go From Here? Lecture Theatre 2 Prof. Madeleine Murtagh, University of Bristol, UK Prof. Eric Juengst, University of North Carolina, USA Prof. Kazuto Kato, Osaka University, Japan Prof. Eric Meslin, Indiana University, USA Prof. Amy McGuire, Baylor College of Medicine, USA Prof. Sigrid Sterckx, Ghent University, Belgium Chair: Prof. Jane Kaye University of Oxford, UK Thurs. 25 June 2015